CTLA4 and neoplasm: High expression of immune checkpoints, such as PD‐L1 (PDCD1LG2), TIM‐3 (HAVCR2), and CTLA‐4 (CTLA4), mediates inhibitory immune responses, thus facilitating tumor immune evasion [6, 7, 8].